Cargando…

Cardiopulmonary exercise testing might be helpful for interpretation of impaired pulmonary function in recovered COVID-19 patients

Besides the impaired lung diffusion capacity, impairment of exercise endurance in recovered patients with COVID-19 should also be considered https://bit.ly/3qrzPDY

Detalles Bibliográficos
Autores principales:	Gao, Yi, Chen, Ruchong, Geng, Qian, Mo, Xiaoneng, Zhan, Chen, Jian, Wenhua, Li, Shiyue, Zheng, Jinping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Agora
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758779/ https://www.ncbi.nlm.nih.gov/pubmed/33361097 http://dx.doi.org/10.1183/13993003.04265-2020

Ejemplares similares

Impaired pulmonary function in discharged patients with COVID-19: more work ahead
por: Chen, Ruchong, et al.
Publicado: (2020)

Abnormal pulmonary function in COVID-19 patients at time of hospital discharge
por: Mo, Xiaoneng, et al.
Publicado: (2020)

Why asthma might surprisingly protect against poor outcomes in COVID-19
por: Farne, Hugo, et al.
Publicado: (2020)

Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors
por: Rinaldo, Rocco Francesco, et al.
Publicado: (2021)

Exercise capacity impairment after COVID-19 pneumonia is mainly caused by deconditioning
por: Jahn, Kathleen, et al.
Publicado: (2022)

Iron bioavailability and cardiopulmonary function during ascent to very high altitude
por: Holdsworth, David A., et al.
Publicado: (2020)

Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection
por: Trinkmann, Frederik, et al.
Publicado: (2021)

Does bronchoscopy help the diagnosis in COVID-19 infection?
por: Ora, Josuel, et al.
Publicado: (2020)

Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
por: Bi, Jianping, et al.
Publicado: (2020)

Caution in interpretation of abnormal carbon monoxide diffusion capacity in COVID-19 patients
por: Chapman, David G., et al.
Publicado: (2021)

Acute respiratory distress syndrome is associated with impaired alveolar macrophage efferocytosis
por: Mahida, Rahul Y., et al.
Publicado: (2021)

Short-term outcomes of COVID-19 and risk factors for progression
por: Long, Li, et al.
Publicado: (2020)

Low physical functioning and impaired performance of activities of daily life in COVID-19 patients who survived hospitalisation
por: Belli, Stefano, et al.
Publicado: (2020)

The influence of preventive strategies on the COVID-2019 epidemic in Shenzhen, China
por: Yang, Kai, et al.
Publicado: (2020)

Pulmonary embolism in patients with COVID-19 pneumonia
por: Bompard, Florian, et al.
Publicado: (2020)

Effect of pirfenidone on cough in patients with idiopathic pulmonary fibrosis
por: van Manen, Mirjam J.G., et al.
Publicado: (2017)

Concomitant medications and clinical outcomes in idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2019)

Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis
por: Glassberg, Marilyn K., et al.
Publicado: (2019)

Initial combination therapy of macitentan and tadalafil in pulmonary arterial hypertension
por: Sitbon, Olivier, et al.
Publicado: (2020)

Oral iron supplementation with ferric maltol in patients with pulmonary hypertension
por: Olsson, Karen M., et al.
Publicado: (2020)

Leveraging ageing models of pulmonary fibrosis: the efficacy of nintedanib in ageing
por: Kato, Kosuke, et al.
Publicado: (2021)

The use of online visual analogue scales in idiopathic pulmonary fibrosis
por: Moor, Catharina C., et al.
Publicado: (2022)

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
por: Stewart, Iain D., et al.
Publicado: (2021)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis
por: Jacob, Joseph, et al.
Publicado: (2019)

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: clinical characteristics and progression to carcinoid tumour
por: Sun, Thomas Yang, et al.
Publicado: (2022)

Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease?
por: Sofianopoulou, Eleni, et al.
Publicado: (2020)

In vivo demonstration of pulmonary microvascular involvement in COVID-19 using dual-energy computed tomography
por: Si-Mohamed, Salim, et al.
Publicado: (2020)

COVID-19 and nicotine as a mediator of ACE-2
por: Leung, Janice M., et al.
Publicado: (2020)

Reply to: “Current smoking is not associated with COVID-19”
por: Leung, Janice M., et al.
Publicado: (2020)

Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
por: Eapen, Mathew Suji, et al.
Publicado: (2020)

Pulmonary embolism in COVID-19: D-dimer threshold selection should not be based on maximising Youden's index
por: Korevaar, Daniël A., et al.
Publicado: (2021)

More awareness is needed for severe acute respiratory syndrome coronavirus 2019 transmission through exhaled air during non-invasive respiratory support: experience from China
por: Guan, Lili, et al.
Publicado: (2020)

FVC variability in patients with idiopathic pulmonary fibrosis and role of 6-min walk test to predict further change
por: Nathan, Steven D., et al.
Publicado: (2020)

The potential and challenges of radiomics in uncovering prognostic and molecular differences in interstitial lung disease associated with systemic sclerosis
por: Zhang, Lu, et al.
Publicado: (2022)

Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: is there a role for pre-test probability scores and home treatment?
por: Porfidia, Angelo, et al.
Publicado: (2021)

Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission and role for pre-test probability scores and home treatment
por: Jevnikar, Mitja, et al.
Publicado: (2021)

Diagnostic sensitivity of SILVAMP TB-LAM (FujiLAM) point-of-care urine assay for extra-pulmonary tuberculosis in people living with HIV
por: Kerkhoff, Andrew D., et al.
Publicado: (2020)

Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication
por: Chen, Mengfei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fu4rpc8lphmeh1m17g4e2vhjr6